Online Diabetes Education Project (ODEP)

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT04743778
Collaborator
(none)
12
1
2
6
2

Study Details

Study Description

Brief Summary

This pilot randomized control trial will be testing an empowerment-based virtual group diabetes self-management education and support (DSME/S) for African American/Black adults with type 2 diabetes living in Detroit. Participants will be randomized to either a control group or the virtual DSME/S group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Virtual Diabetes Self-Management Education and Support
  • Behavioral: Resources
N/A

Detailed Description

This pilot randomized control trial will be testing an empowerment-based virtual group diabetes self-management education and support (DSME/S) for African American/Black adults with type 2 diabetes living in Detroit. Participants interested in participating in this study will first be consented then they will complete a baseline health assessment including a questionnaire and physiologic testing. Using a 50/50 randomization scheme, participants will be randomized to either a control group or the virtual DSME/S group and be told of their placement. Participants randomized to the control group will receive community resources, diabetes specific newsletters, and pedometers. Participants randomized to the virtual DSME/S group will receive 10-weekly 1-hour virtual DSME/S sessions with a certified diabetes care and education specialists through Zoom for Health at the University of Michigan, a HIPPA compliant platform. After the intervention is complete and then again 3 months later, participants in both groups will be invited to complete an additional health assessment.

Study Design

Study Type:
Interventional
Actual Enrollment :
12 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Online Diabetes Education Project: Virtual Diabetes Self-Management Education and Support Intervention
Actual Study Start Date :
Aug 1, 2021
Actual Primary Completion Date :
Dec 20, 2021
Actual Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual Diabetes Self-Management Education and Support

Participants randomized into the virtual empowerment-based DSME/S group will receive one hour of DSME/S delivered by a Certified Diabetes Care and Education Specialist (CDCES) per week for 10 weeks delivered via the Zoom for Health at U-M service may be used for Protected Health Information (PHI, regulated by HIPAA). To ensure treatment fidelity, three DSME/S sessions will be selected at random and recorded and rated for fidelity to the above content by our research team.

Behavioral: Virtual Diabetes Self-Management Education and Support
Diabetes self-management education and support delivered through Zoom for health.

Active Comparator: Control Group

Participants randomized to enhanced usual care will receive referrals to community mental health providers, pedometers, gym memberships to a community-based venue, and intervention patient manuals. Based on several years of experience in Detroit, providing all participants with referrals, pedometers, and educational materials minimizes ethical concerns regarding assignment of underserved populations to receive a no-treatment control.

Behavioral: Resources
Newsletters, pedometers, and community resources.

Outcome Measures

Primary Outcome Measures

  1. Metabolic Control of A1c [6 months]

    Measured using the DCA 2000 point-of-care testing instrument

  2. Depression [6 months]

    Measured using the PHQ-9 (score >=10) and the BDI-II

  3. Regimen adherence [6 months]

    Measured using the Perceived Diabetes Self-Management Scale, a self-report questionnaire used to measure a broad range of management behaviors, such as insulin management, dietary management, blood glucose monitoring, symptom response, and parent assistance/supervision.

Secondary Outcome Measures

  1. BMI [6 months]

    Calculated using height and weight. Height will be measured using a stadiometer. Weight will be measured on a high quality, calibrated digital scale.

  2. Blood pressure [6 months]

    Measured using the auscultatory method.

  3. Diabetes Social Support [6 months]

    Measured using the Diabetes Social Support Questionnaire

  4. Diabetes-related Distress [6 months]

    Measured using the Diabetes Distress Scale (SF-12)

  5. Diabetes Quality of Life [6 months]

    Measured using the Diabetes Quality of Life Questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Agee 18 or older, Black, a diagnosis of T2D for one year duration or longer, ambulatory status.
Exclusion Criteria:
  • Non-ambulatory, serious health conditions (morbid obesity and severe symptomatic heart disease, visual impairment, renal failure, and peripheral neuropathy), psychiatric illness (severity requiring hospitalization) or cognitive deficit (illness determined using the Montreal Cognitive Assessment tool) and serious diabetes complications (e.g. blindness) that would impede meaningful participation

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jaclynn Hawkins, Assistant Professor, University of Michigan
ClinicalTrials.gov Identifier:
NCT04743778
Other Study ID Numbers:
  • ODEP HUM00190508
First Posted:
Feb 8, 2021
Last Update Posted:
Jun 13, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 13, 2022